Published in N Engl J Med on December 31, 1992
History of Hepatitis C in Volunteer Blood Donors | NCT00001982
Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med (2001) 8.47
Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol (2006) 6.00
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci U S A (2005) 3.83
Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A (1994) 3.76
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56
Hybrid DNA virus in Chinese patients with seronegative hepatitis discovered by deep sequencing. Proc Natl Acad Sci U S A (2013) 3.35
Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A (1995) 3.30
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A (1996) 3.25
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health (1995) 3.24
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci U S A (1995) 3.20
Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest (1997) 2.99
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J Virol (2005) 2.85
Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system. J Clin Microbiol (1996) 2.72
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest (1995) 2.66
Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol (2006) 2.65
Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci U S A (2003) 2.64
Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology (2013) 2.62
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol (1993) 2.57
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol (1997) 2.55
Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog (2010) 2.48
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol (1996) 2.47
Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev (2000) 2.45
Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol (2002) 2.31
A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J Virol (1995) 2.26
Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol (1999) 2.24
Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Trent Regional Hepatitis C Virus Study Group. BMJ (1994) 2.22
Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol (2002) 2.05
Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol (1999) 1.98
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol (1999) 1.93
Replication of a hepatitis C virus replicon clone in mouse cells. Virol J (2006) 1.90
Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy. J Theor Biol (2007) 1.89
Prevention and treatment of hepatitis C in injection drug users. Hepatology (2002) 1.88
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut (2000) 1.84
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology (2012) 1.82
Clinical guidelines on the management of hepatitis C. Gut (2001) 1.72
Preventive care in chronic liver disease. J Gen Intern Med (1999) 1.69
Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol (2005) 1.67
Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J Virol (1999) 1.63
Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci U S A (1994) 1.60
Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut (1999) 1.60
Burden of disease and cost of chronic hepatitis C infection in Canada. Can J Gastroenterol Hepatol (2014) 1.59
Liver fibrosis progression in hepatitis C virus infection after seroconversion. JAMA Intern Med (2015) 1.55
The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut (2001) 1.51
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut (1999) 1.49
Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol (1998) 1.48
The hepatitis C sequence database in Los Alamos. Nucleic Acids Res (2007) 1.45
Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut (2004) 1.42
Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a. J Clin Microbiol (2001) 1.42
HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice. PLoS Pathog (2009) 1.40
Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J Virol (1999) 1.40
The epidemiology of aplastic anemia in Thailand. Blood (2005) 1.38
Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. J Virol (1996) 1.38
Parenchymal liver disease in the elderly. Gut (1997) 1.38
Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37
Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med (1999) 1.36
Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr (2006) 1.32
Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death. Virology (2008) 1.32
Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics (2003) 1.30
Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis (2008) 1.30
Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health (1997) 1.28
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. Vaccine (2010) 1.28
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.27
Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut (1999) 1.26
Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons. J Clin Microbiol (2004) 1.26
Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis. Dig Dis Sci (1997) 1.25
Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol (2003) 1.25
Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. PLoS Pathog (2008) 1.24
A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol (1993) 1.23
Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol (2009) 1.23
Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci (2005) 1.21
Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells. J Virol (2006) 1.21
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol (2000) 1.18
Population-based surveillance for hepatitis C virus, United States, 2006-2007. Emerg Infect Dis (2009) 1.17
HCV and HIV co-infection: mechanisms and management. Nat Rev Gastroenterol Hepatol (2014) 1.16
Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol (2008) 1.16
Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J Virol (2005) 1.16
Temporal variations in the hepatitis C virus intrahost population during chronic infection. J Virol (2011) 1.15
Acute hepatitis C virus infection: a chronic problem. Hepatology (2008) 1.15
KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol (2016) 1.15
Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum. J Clin Microbiol (2002) 1.14
Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother (2001) 1.14
Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization. J Virol (2011) 1.13
Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J Clin Microbiol (2004) 1.12
Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health (2013) 1.12
Consensus siRNA for inhibition of HCV genotype-4 replication. Virol J (2009) 1.10
Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. J Urban Health (2004) 1.10
Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C. Gastroenterology (2011) 1.09
Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA. J Clin Microbiol (1999) 1.09
Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission. J Clin Microbiol (1997) 1.08
Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. J Virol (1996) 1.08
Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLoS Comput Biol (2013) 1.07
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med (1999) 16.35
Antibodies to ribosomes in chronic active hepatitis. Gastroenterology (1979) 12.78
The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA (1990) 6.09
An outbreak of influenza aboard a commercial airliner. Am J Epidemiol (1979) 5.51
Fear of AIDS and gonorrhea rates in homosexual men. Lancet (1983) 5.02
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol (1997) 4.52
Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med (1986) 4.51
Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med (2000) 4.08
Screening for gonorrhea and syphilis in the gay baths--Denver, Colorado. Am J Public Health (1977) 4.04
The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med (1982) 3.69
A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med (1992) 3.65
The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology (1998) 3.60
Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health (1999) 3.55
The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology (2000) 3.53
Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA (1990) 3.41
Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA (1989) 3.39
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25
Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem (1995) 3.22
A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N Engl J Med (1999) 3.09
Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest (1997) 3.07
Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis (1982) 2.96
Long-term outcomes of persons with Lyme disease. JAMA (2000) 2.96
Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med (1997) 2.90
Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80
Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol (1992) 2.74
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol (2001) 2.69
The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies. J Infect Dis (1998) 2.68
Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis (1998) 2.67
Are endoscopic measurements of colonic polyps reliable? Am J Gastroenterol (1993) 2.64
Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med (1995) 2.61
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med (1990) 2.53
Antenatal microbiologic and maternal risk factors associated with prematurity. Am J Obstet Gynecol (1990) 2.44
Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol (1997) 2.43
Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med (1971) 2.41
The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther (2005) 2.40
Pseudomonas folliculitis acquired from a health spa whirlpool. JAMA (1978) 2.36
Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc (1997) 2.36
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol (2000) 2.29
Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures. J Clin Microbiol (1987) 2.21
Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet (2000) 2.18
Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol (1989) 2.18
Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc (1991) 2.17
Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med (1970) 2.16
Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health (1992) 2.16
Multicenter comparative evaluation of two rapid microscopic methods and culture for detection of Chlamydia trachomatis in patient specimens. J Clin Microbiol (1988) 2.12
Colon cancer reduction. Questions about implementation of proven techniques. Arch Intern Med (1997) 2.12
Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst (1990) 2.11
Host factors related to poor immunogenicity of hepatitis B vaccine in adults. Another reason to immunize early. JAMA (1994) 2.03
Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. J Infect Dis (1996) 2.00
Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex Transm Dis (2000) 2.00
Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci (1999) 1.98
Hepatitis E virus: identification of type-common epitopes. J Virol (1991) 1.95
Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am J Public Health (2001) 1.94
In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J Gen Virol (1993) 1.93
Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J Med Virol (1991) 1.93
The aetiological agent of cat scratch disease. Lancet (1985) 1.93
Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol (1988) 1.92
Short-term incarceration for the management of noncompliance with tuberculosis treatment. Chest (1997) 1.91
Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr (1986) 1.89
Treatment of uncomplicated gonorrhea with rosoxacin. Antimicrob Agents Chemother (1981) 1.88
A multistate outbreak of hepatitis A caused by the consumption of raw oysters. Am J Public Health (1991) 1.85
Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med (1992) 1.85
Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol (2001) 1.84
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol (1997) 1.81
Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut (2003) 1.81
Comparative prevalence rates of sexually transmitted diseases in heterosexual and homosexual men. Am J Epidemiol (1980) 1.81
Role of mRNA competition in regulating translation: further characterization of mRNA discriminatory initiation factors. Proc Natl Acad Sci U S A (1983) 1.81
Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis (2001) 1.81
Micronitrous acid extraction-coagglutination test for rapid diagnosis of streptococcal pharyngitis. J Clin Microbiol (1983) 1.79
Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med (1983) 1.79
Short segment Barrett's esophagus--the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol (1998) 1.77
Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis (1991) 1.75
Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis (1997) 1.75
Mechanization of library procedures in the medium-sized medical library. XI. Two methods of providing selective dissemination of information to medical scientists. Bull Med Libr Assoc (1970) 1.74
Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA (1988) 1.74
Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74
Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug Alcohol Depend (1999) 1.74
Inhibition by streptomycin of tubercle bacilli within cultured human macrophages. Am Rev Respir Dis (1984) 1.74
Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr (1985) 1.73
Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis (2001) 1.73